Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,530
datasets available to search
ShareScore release 0.9.0
Dataset results
3,530 results for “Non-small cell lung cancer”
Efficacy and Safety of JMT101 Combined With Afatinib (or Osimertinib) in Patients With Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT04448379. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Bavituximab Plus Paclitaxel and Carboplatin in Patients With Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00687817. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Combination Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT00003589. IPD Sharing: Not stated. Countries: 12. Publications: 3.
First in Human Study of BAY2927088 in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations in the Genes of Epidermal Growth Factor Receptor (EGFR) and/or Human Epidermal Gr
ClinicalTrials.gov study NCT05099172. IPD Sharing: NO. Countries: 15. Publications: 1.
Observational Cohort Study of Advanced Non-small Cell Lung Cancer (CAPTRA-LUNG)
ClinicalTrials.gov study NCT03334864. IPD Sharing: NO. Countries: 1. Publications: 1.
Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib
ClinicalTrials.gov study NCT06120140. IPD Sharing: YES. Countries: 11. Publications: 0.
Erlotinib in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00085280. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Efficacy and Safety of JDQ443 Single-agent as First-line Treatment for Patients With Locally Advanced or Metastatic KRAS G12C- Mutated Non-small Cell Lung Cancer With a PD-L1 Expression < 1%
ClinicalTrials.gov study NCT05445843. IPD Sharing: YES. Countries: 19. Publications: 0.
Comparison of Two Combination Chemotherapy Regimens in Treating Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT00006004. IPD Sharing: Not stated. Countries: 4. Publications: 1.
Safety, Efficacy, and Survival Outcomes of Neoadjuvant/Induction Immunotherapy in Surgical and Radiotherapeutic Management of Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT06926179. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase I/II Clinical Study of SAF-189s in Non-small Cell Lung Cancer (NSCLC) Patients
ClinicalTrials.gov study NCT04237805. IPD Sharing: NO. Countries: 1. Publications: 2.
A Study of SKB264 in Combination With Pembrolizumab Versus Pembrolizumab in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT06448312. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of MGCD265 Given With Erlotinib or Docetaxel in Subjects With Advanced Malignancies or Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00975767. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Immune Neoadjuvant Therapy Study of Durvalumab in Early Stage Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT03030131. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Combination Checkpoint Inhibitor Plus Erlotinib or Crizotinib for EGFR or ALK Mutated Stage IV Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT01998126. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Pulmonary Magnetic Resonance-guided Online Adaptive Radiotherapy of Locally Advanced Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT05237453. IPD Sharing: NO. Countries: 1. Publications: 1.
Evaluating Efficacy and Safety of Anlotinib Combined With Concurrent Chemoradiotherapy Followed by Consolidation Immunotherapy for Locally Advanced Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT05481775. IPD Sharing: Not stated. Countries: 1. Publications: 14.
Combination Chemotherapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00054392. IPD Sharing: Not stated. Countries: 1. Publications: 4.
A Phase I Study of XZP-3621 in Chinese Patients With ALK or ROS1 Rearrangement Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT05055232. IPD Sharing: Not stated. Countries: 1. Publications: 1.
First Line Osimertinib for EGFR Mutation-positive Non-Small Cell Lung Cancer in Real World Chinese Setting
ClinicalTrials.gov study NCT04391283. IPD Sharing: NO. Countries: 1. Publications: 10.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.